Column

Pharma Insights

Journeying Through the Past, Present, and Future of Medicare Part D

06/17/2020

Andrew Cournoyer, RPh, MBA

Charline Shan, RPh, MPh

Larry Blandford, PharmD—Column Editor

This article explores the beginnings of Medicare Part D and the different dynamics driving current and future change for various stakeholders including the Centers for Medicare & Medicaid Services, plan sponsors,...

This...

06/17/2020

Journal of Clinical Pathways

Engaging Payers

Partnership in Value-Based Care: Becoming and Finding Good Teammates

05/19/2020

Lili Brillstein, MPH—Column Editor

Value-based care is a whole-person philosophy that relies on the diverse expertise of various stakeholders and the ability of each and all to effectively collaborate to deliver the most effective and comprehensive...

...

05/19/2020

Journal of Clinical Pathways

Editor's Page

Making the Most of Data: Improving EHRs and Gleaning Insight From RWD

05/19/2020

Winston Wong, PharmD, Editor-in-Chief

Electronic health records (EHRs) can improve the ability to diagnose diseases, reduce medical errors, and improve patient outcomes. However, data collection platforms are only as good as their design and usability....

...

05/19/2020

Journal of Clinical Pathways

Pharma Insights

Real-World Data Will Continue to Provide Real Value to the Drug Development and Commercialization Process

05/19/2020

Sajjad Raza, MD, PhD, MSM

Kathy Lang, PhD

Randomized controlled trials provide critically needed evidence of drugs’ safety and efficacy, yet their results are not always generalizable to diverse populations in less idealized settings. Thus, we need data...

...

05/19/2020

Journal of Clinical Pathways

Trending From ACCC

Telehealth in the Wake of COVID-19

05/19/2020

JCP Editors

In early December 2019, the Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute hosted a Telemedicine Roundtable, convening Institute leadership and experts from relevant areas of health care....

In...

05/19/2020

Journal of Clinical Pathways

Clinical Pathways GPS

How COVID-19 Will Change the Patient Journey, Reimbursement, and Care Delivery

05/19/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor

Value-based care has led to much change in health care over the years, and COVID-19 is pushing change faster and even further. These changes forced by COVID-19 will have long-term effects on every aspect of care...

...

05/19/2020

Journal of Clinical Pathways

Editor's Page

Enhancing Use of Technology and Advanced Practice Practitioners to Improve Outcomes

04/21/2020

Winston Wong, PharmD, Editor-in-Chief

The current coronavirus pandemic, COVID-19, has changed our daily lives in the blink of an eye. It has also brought widespread attention back to how the health care system and market dynamics impact how care is...

The...

04/21/2020

Journal of Clinical Pathways

Editorial

Attend #COA2020 to Prepare for What’s Next in Community Oncology

04/21/2020

Nicolas Ferreyros, Managing Director, Community Oncology Alliance

Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic. This challenge to...

...

04/21/2020

Journal of Clinical Pathways

Trending From ACCC

Cancer Care in the Time of COVID-19

04/21/2020

Randall A Oyer, MD, ACCC President 2020-2021

As a community-spread disease, coronavirus 2019 shows us the importance of community—from global, national, state, local, workplace, and individual perspectives. On March 11, 2020, World Health Organization...

As a...

04/21/2020

Journal of Clinical Pathways

Pharma Insights

Equivalars: Could They Bring Down the Cost of Rx Drugs?

04/21/2020

Sejal Jonas, PharmD1

Larry Blandford, PharmD2—Column Editor

A recent announcement that new biotech start-up, EQRx plans to launch “equivalars,” alternatives to a number of currently patented costly drugs at far lower price points, introduces another disruptive solution trying...

A...

04/21/2020

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products